Iranian Journal of Diabetes and Obesity
Shahid Sadoughi University Of Medical Sciences
Sat, Apr 27, 2024
[Archive]
| Post date: 2024/01/16 |
Authorship and Acknowledgements:
Based on the Recommendations for the Conduct, Reporting, Editing and Publication of Scholarly Work in Medical Journals, By the International Committee of Medical Journal Editors (ICMJE), Authors should have made significant conceptual, intellectual, experimental, and analytical contributions to the research, as well as having participated in writing and revising the manuscript. Hence, we want authors to read these recommendations before their manuscript submission.
Also each author should have participated sufficiently in the work to be responsible for its content. Each author should meet all criteria (A, B, C, and D) that recommended by the ICMJE as following conditions:
1. Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; AND
2. Drafting the work or revising it critically for important intellectual content; AND
3. Final approval of the version to be published; AND
4. Agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.
Each author should be accountable for the parts of the work he or she has done. In addition, each author should be able to identify which coauthors are responsible for specific other parts of the work and should have confidence in the integrity of the contributions of any coauthors.
The authors also must certify that the manuscript represents valid data and has not been published in any form and is not being submitted for in the form of scientific presentations for publication elsewhere.
If requested, authors should be prepared to provide the data and must cooperate fully in obtaining and providing the data on which the manuscript is based for examination by the editors or their assignees.
We asked the authors to appreciate and accept that it is necessary to say the funding that made the investigation possible. Researchers should protect study participants, patients, and experimental animals, and if they are used in research and publications, respect for patients' privacy and anonymity. This journal will follow the guidelines of the Committee on Publication Ethics, COPE (http://publicationethics.org/), and International Committee of Medical Journal Editors, ICMJE (http://www.icmje.org/).
The contributors who do not meet the authorship criteria should be mentioned as “Acknowledgments”.
Changes in Authorship: The authors should be agreed the order of authorship among themselves before submitting the manuscript. Changes in authorship (ie, order, addition, and deletion of authors) should be discussed and approved by all authors. Any requests for such changes in authorship after initial manuscript submission and before publication should be explained in a letter to the editor signed by all the authors or email from all authors.
Authors should:
i. Authors must certify that the submitted manuscript is their original version and has not previously been published in another journal, and neither currently being submitted nor being under reviewed in another journal.
ii. Researchers should adhere to the WMA Declaration of Helsinki - Ethical Principles of Medical Research for Human Studies, and for reporting animal studies, follow international and national guidelines such as the US NIH or the UK Home Office, and mention the recommendations for the care and use of animals.
iii. Authors should correct mistakes in the article in accordance with the comments of the reviewers during the peer review process and report any mistakes in the published article to the Editors.
iv. The names stated in the article as authors should be significantly involved in the investigation and the rate of their collaboration should be specified in the "Authors' Contribution" section of the paper.
v. Real, valid, without fabrication and falsification of every data, result, the method used, etc. in the research must be certified by the authors.
vi. Authors should know any conflicts of interest, financial resources, individuals, and entities who have supported researchers in their research and declare them to the editors.
vii. The authors should express that informed consent was acquired from all adult patients and their parents by the researchers if the children were in the study population.
viii. Authors are recommended to consult with statistical professionals before submitting an article. Because of inaccurate statistical analysis in many cases, delays in evaluating the manuscript and ultimately rejecting the paper.
ix. The corresponding author for each article is the main owner of the paper and is responsible for the following: all connections, submission of the manuscript, revision of the paper, uploading a brief explanation of all contributions to the work in the title page, Paper has not been on prior published or for publication in other journals (in any language) has not sent, can withdraw the article if it is incomplete (before entering the review process or when appealing this article).
Publication and Publishing Ethics considerations
i. Assistant Editors and Editor-in-Chief select at least two subject-related reviewers to evaluate all manuscripts submitted for peer review. Items such as correlation, originality, readability, structure, ethical issues, statistical validation, and language are considered by the referees for review. Possible responses from the reviewers and editor include acceptance, minor review, major review, and rejection (rejected articles will not be re- considered).
ii. There is no warranty that the revised paper will be accepted if the manuscript is requested to be revised and resubmitted to the journal.
iii. Legal requirements such as libel, plagiarism, and copyright breach lead to the journal not accepting the article.
iv. It is not possible to publish any article more than once.
v. The principles explained in ICMJE need to be confirmed and followed by all editorial boards, peer reviewers, and researchers.
vi. Significant changes to the paper are not allowed after acceptance unless the authors have a strong argument for it.
vii. The editorial board and authors of each paper must be honest in publishing the data and corrections and publish them perfectly.
Ethics of studies involving humans and animals
The research that involves human beings must adhere to the principles of the Declaration of Helsinki (http://www.wma.net/en/30publications/10policies/b3/index.html), and for reporting animal studies, follow international and national guidelines such as the US NIH or the UK Home Office, and mention the recommendations for the care and use of animals.
All research participants should be informed about the aims of the study and any possible side effects of the drugs and intervention. Written informed consent under protocols approved by an institutional or local review board or approved animal protocols are essential if the research involves human or animal subjects, respectively. This information should be stated in the manuscript and the protocol number or exempt status of approved protocols should be stated in the manuscript at the time of submission for review.
Ethical considerations must be clearly addressed in the Materials and Methods section. Also the name of the appropriate institutional review board that approved the project should be mentioned.
The Journal reserves the right to request the related documents.
Clinical Trial Registration
According to the International Committee of Medical journal Editors (ICMJE) a Clinical Trial is any research study that prospectively assigns human participants or groups of humans to one or more health-related interventions to evaluate the effects on health outcomes.
Authors of clinical trials are required to prospectively register their trial with one of the ICMJE-recognized trial registries. The registration number of the trial and the name of the trial registry must be mentioned at the end of the abstract.
All of Iranian Clinical Trials must be registered in Iranian Registry of Clinical Trials (www.IRCT.ir), in order to be considered for publication. The clinical trials performed abroad, could be considered for publication, if they register in a registration site approved by W.H.O. such as:
www.rctregistry.tums.ac.ir
www.clicicaltrials.gov
www.anzctr.org.au
www.isrctn.org
www.trialregister.nl/trialreg/index.asp
www.umin.ac.jp/ctr
Randomized control trials:
Randomized controlled trials must be according to The CONSORT Statement guideline.
Committee on Publication Ethics: IJDO is not a member of the Committee on Publication Ethics (COPE) at present, but IJDO members are committed to implementing the principles of COPE on how to handle acts of misconduct thereby committing to investigate allegations of misconduct in order to guarantee the accuracy of research. Also, we are attempting to be a member of COPE in the future.
Plagiarism of text from a previously published manuscript by the same or another author is a serious publication offense. Small amounts of text may be used, but only where the source of the material quoted is clearly acknowledged. Fraudulent data or data stolen from other authors is also unethical and will be treated accordingly. Any alleged offense is considered initially by the Editorial Team. In addition to informing authors and institutions, the editors follow the COPE guidelines for plagiarism. The journal is warranted to keeping the highest level of honesty in the context published.
Fabrication/ Falsification: If the reviewers of the article doubt the existence of data and methods, etc. of the research under review, the author is asked to provide raw data of the study, if necessary, for further research. IJDO journal seeks and acts in accordance with COPE guidelines if it encounters such issues.
Retraction Policy: The IJDO for retraction of a published article uses the COPE flowchart (http://publicationethics.org/resources/guidelines)
International Committee of Medical Journal Editors, ICMJE (http://www.icmje.org/). The journal uses iThenticate plagiarism detection software to evaluate the originality of each manuscript. The journal reserves the right to report the allegations to the author’s institution or any other agency
Editorial duties
i. Editors (Assistant Editors or Editor-in-Chief) have complete liability and authority to reject/accept a paper. They must not invert their determinations after making a decision (particularly after reject or accept) unless they have a key argument.
ii. It is the responsibility of the editors to guarantee the quality of the articles, the contents, and the overall quality of the publication.
iii. Editors need to pay attention to the needs of writers and readers to improve publishing.
iv. Work funding sources should be clear to editors.
v. The importance, originality, transparency, and relevance of research to the scope of the journal should be considered by editors when deciding on an article.
vi. Editors must keep the anonymity of the reviewers.
vii. Editors must certify that internationally accepted ethical recommendation is followed in all published research work.
viii. Editors should only accept reasonable papers.
ix. If editors suspect that there is misconduct in an article (published or unpublished paper), they should attempt to prove and resolve the problem and only reject the article if the abuse is proven.
x. Editors should not authorize any conflicts of interest among staff, researchers, referees, and editorial members.
Accountability for the Peer reviewers
i. Submitted articles must be kept confidential and the peer reviewers must not fraud the data of the articles and at the time of publication, they cannot be used in any way.
ii. Evaluations should be conducted objectively and without personal criticism of the author, and the authors' recognition should not influence the opinions and decisions of the referees.
iii. The reviewers must express their opinions with supporting arguments in a maximum of 1000 words.
iv. The reviewers may be aware of the existence of a published paper that has not been cited by the authors. In such a situation, the reviewers should discuss any fundamental similarities and overlaps between the version under review and any other published article with the editor of the journal.
v. Manuscripts containing various reasons, such as competition, partnership, or another connections with any of the researchers and institutions involved in the conflict of interest articles, should not be assessed by the reviewers.
Copyright Policy
Open Access (OA)
All articles published in IJDO are open access which means the articles are freely available online for anyone to download and use the providing address to the individual authors. In IJDO as an open access journal, authors sign a publishing agreement where they will have copyright but grant broad publishing and distribution rights to the publisher, including the right to publish the article on IJDO's website and choose the end-user license under which readers can use and share the articles. Then IJDO provides the article's online access for using and sharing by readers. Permitted (re) use is defined by Creative Commons Attribution (CC BY 4.0).
Creative Commons Attribution (CC BY 4.0): permit users to copy, to create extracts abstracts, abstracts and new works from the article, to alter and revise the article, and to make commercial use of the article
Copyright Form
Conflicts of interest
All authors must inform us about any kind of financial, personal, political, or academic "Conflict of Interest that would potentially affect their judgment. Authors are preferably asked to fill the uniform disclosure form available through: (http://www.icmje.org/coi_disclosure.pdf). We then use the COPE guidelines to clearly deal with it.
Page fee
There is no fee for submission, review, or publishing an article in this journal in both online and print forms.
Advertising policy
The journal does not carry advertising (neither print nor online).
Complaints and appeals
We hope this never happens, but if you do, the best way to contact us is by email (ijdo2009
gmail.com). The complaint should clearly include the subject, person, or event related to the IJDO. The relevant member of the editorial board will review the complaint as soon as possible, and if the problem is not resolved, the complaints will be referred to the IJDO editorial board and complete response will be provided within a week. If the problem is not resolved, the complaint will be sent to the Research Ethics Committee of Shahid Sadoughi University and will be answered within four weeks. If the plaintiff remains dissatisfied, a complaint must be sent to the chief administrator of Shahid Sadoughi University of Medical Sciences, which ends with his decision.
Notice
Based on the Recommendations for the Conduct, Reporting, Editing and Publication of Scholarly Work in Medical Journals, By the International Committee of Medical Journal Editors (ICMJE), Authors should have made significant conceptual, intellectual, experimental, and analytical contributions to the research, as well as having participated in writing and revising the manuscript. Hence, we want authors to read these recommendations before their manuscript submission.
Also each author should have participated sufficiently in the work to be responsible for its content. Each author should meet all criteria (A, B, C, and D) that recommended by the ICMJE as following conditions:
1. Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; AND
2. Drafting the work or revising it critically for important intellectual content; AND
3. Final approval of the version to be published; AND
4. Agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.
Each author should be accountable for the parts of the work he or she has done. In addition, each author should be able to identify which coauthors are responsible for specific other parts of the work and should have confidence in the integrity of the contributions of any coauthors.
The authors also must certify that the manuscript represents valid data and has not been published in any form and is not being submitted for in the form of scientific presentations for publication elsewhere.
If requested, authors should be prepared to provide the data and must cooperate fully in obtaining and providing the data on which the manuscript is based for examination by the editors or their assignees.
We asked the authors to appreciate and accept that it is necessary to say the funding that made the investigation possible. Researchers should protect study participants, patients, and experimental animals, and if they are used in research and publications, respect for patients' privacy and anonymity. This journal will follow the guidelines of the Committee on Publication Ethics, COPE (http://publicationethics.org/), and International Committee of Medical Journal Editors, ICMJE (http://www.icmje.org/).
The contributors who do not meet the authorship criteria should be mentioned as “Acknowledgments”.
Changes in Authorship: The authors should be agreed the order of authorship among themselves before submitting the manuscript. Changes in authorship (ie, order, addition, and deletion of authors) should be discussed and approved by all authors. Any requests for such changes in authorship after initial manuscript submission and before publication should be explained in a letter to the editor signed by all the authors or email from all authors.
Authors should:
i. Authors must certify that the submitted manuscript is their original version and has not previously been published in another journal, and neither currently being submitted nor being under reviewed in another journal.
ii. Researchers should adhere to the WMA Declaration of Helsinki - Ethical Principles of Medical Research for Human Studies, and for reporting animal studies, follow international and national guidelines such as the US NIH or the UK Home Office, and mention the recommendations for the care and use of animals.
iii. Authors should correct mistakes in the article in accordance with the comments of the reviewers during the peer review process and report any mistakes in the published article to the Editors.
iv. The names stated in the article as authors should be significantly involved in the investigation and the rate of their collaboration should be specified in the "Authors' Contribution" section of the paper.
v. Real, valid, without fabrication and falsification of every data, result, the method used, etc. in the research must be certified by the authors.
vi. Authors should know any conflicts of interest, financial resources, individuals, and entities who have supported researchers in their research and declare them to the editors.
vii. The authors should express that informed consent was acquired from all adult patients and their parents by the researchers if the children were in the study population.
viii. Authors are recommended to consult with statistical professionals before submitting an article. Because of inaccurate statistical analysis in many cases, delays in evaluating the manuscript and ultimately rejecting the paper.
ix. The corresponding author for each article is the main owner of the paper and is responsible for the following: all connections, submission of the manuscript, revision of the paper, uploading a brief explanation of all contributions to the work in the title page, Paper has not been on prior published or for publication in other journals (in any language) has not sent, can withdraw the article if it is incomplete (before entering the review process or when appealing this article).
Publication and Publishing Ethics considerations
i. Assistant Editors and Editor-in-Chief select at least two subject-related reviewers to evaluate all manuscripts submitted for peer review. Items such as correlation, originality, readability, structure, ethical issues, statistical validation, and language are considered by the referees for review. Possible responses from the reviewers and editor include acceptance, minor review, major review, and rejection (rejected articles will not be re- considered).
ii. There is no warranty that the revised paper will be accepted if the manuscript is requested to be revised and resubmitted to the journal.
iii. Legal requirements such as libel, plagiarism, and copyright breach lead to the journal not accepting the article.
iv. It is not possible to publish any article more than once.
v. The principles explained in ICMJE need to be confirmed and followed by all editorial boards, peer reviewers, and researchers.
vi. Significant changes to the paper are not allowed after acceptance unless the authors have a strong argument for it.
vii. The editorial board and authors of each paper must be honest in publishing the data and corrections and publish them perfectly.
Ethics of studies involving humans and animals
The research that involves human beings must adhere to the principles of the Declaration of Helsinki (http://www.wma.net/en/30publications/10policies/b3/index.html), and for reporting animal studies, follow international and national guidelines such as the US NIH or the UK Home Office, and mention the recommendations for the care and use of animals.
All research participants should be informed about the aims of the study and any possible side effects of the drugs and intervention. Written informed consent under protocols approved by an institutional or local review board or approved animal protocols are essential if the research involves human or animal subjects, respectively. This information should be stated in the manuscript and the protocol number or exempt status of approved protocols should be stated in the manuscript at the time of submission for review.
Ethical considerations must be clearly addressed in the Materials and Methods section. Also the name of the appropriate institutional review board that approved the project should be mentioned.
The Journal reserves the right to request the related documents.
Clinical Trial Registration
According to the International Committee of Medical journal Editors (ICMJE) a Clinical Trial is any research study that prospectively assigns human participants or groups of humans to one or more health-related interventions to evaluate the effects on health outcomes.
Authors of clinical trials are required to prospectively register their trial with one of the ICMJE-recognized trial registries. The registration number of the trial and the name of the trial registry must be mentioned at the end of the abstract.
All of Iranian Clinical Trials must be registered in Iranian Registry of Clinical Trials (www.IRCT.ir), in order to be considered for publication. The clinical trials performed abroad, could be considered for publication, if they register in a registration site approved by W.H.O. such as:
www.rctregistry.tums.ac.ir
www.clicicaltrials.gov
www.anzctr.org.au
www.isrctn.org
www.trialregister.nl/trialreg/index.asp
www.umin.ac.jp/ctr
Randomized control trials:
Randomized controlled trials must be according to The CONSORT Statement guideline.
Committee on Publication Ethics: IJDO is not a member of the Committee on Publication Ethics (COPE) at present, but IJDO members are committed to implementing the principles of COPE on how to handle acts of misconduct thereby committing to investigate allegations of misconduct in order to guarantee the accuracy of research. Also, we are attempting to be a member of COPE in the future.
Plagiarism of text from a previously published manuscript by the same or another author is a serious publication offense. Small amounts of text may be used, but only where the source of the material quoted is clearly acknowledged. Fraudulent data or data stolen from other authors is also unethical and will be treated accordingly. Any alleged offense is considered initially by the Editorial Team. In addition to informing authors and institutions, the editors follow the COPE guidelines for plagiarism. The journal is warranted to keeping the highest level of honesty in the context published.
Fabrication/ Falsification: If the reviewers of the article doubt the existence of data and methods, etc. of the research under review, the author is asked to provide raw data of the study, if necessary, for further research. IJDO journal seeks and acts in accordance with COPE guidelines if it encounters such issues.
Retraction Policy: The IJDO for retraction of a published article uses the COPE flowchart (http://publicationethics.org/resources/guidelines)
International Committee of Medical Journal Editors, ICMJE (http://www.icmje.org/). The journal uses iThenticate plagiarism detection software to evaluate the originality of each manuscript. The journal reserves the right to report the allegations to the author’s institution or any other agency
Editorial duties
i. Editors (Assistant Editors or Editor-in-Chief) have complete liability and authority to reject/accept a paper. They must not invert their determinations after making a decision (particularly after reject or accept) unless they have a key argument.
ii. It is the responsibility of the editors to guarantee the quality of the articles, the contents, and the overall quality of the publication.
iii. Editors need to pay attention to the needs of writers and readers to improve publishing.
iv. Work funding sources should be clear to editors.
v. The importance, originality, transparency, and relevance of research to the scope of the journal should be considered by editors when deciding on an article.
vi. Editors must keep the anonymity of the reviewers.
vii. Editors must certify that internationally accepted ethical recommendation is followed in all published research work.
viii. Editors should only accept reasonable papers.
ix. If editors suspect that there is misconduct in an article (published or unpublished paper), they should attempt to prove and resolve the problem and only reject the article if the abuse is proven.
x. Editors should not authorize any conflicts of interest among staff, researchers, referees, and editorial members.
Accountability for the Peer reviewers
i. Submitted articles must be kept confidential and the peer reviewers must not fraud the data of the articles and at the time of publication, they cannot be used in any way.
ii. Evaluations should be conducted objectively and without personal criticism of the author, and the authors' recognition should not influence the opinions and decisions of the referees.
iii. The reviewers must express their opinions with supporting arguments in a maximum of 1000 words.
iv. The reviewers may be aware of the existence of a published paper that has not been cited by the authors. In such a situation, the reviewers should discuss any fundamental similarities and overlaps between the version under review and any other published article with the editor of the journal.
v. Manuscripts containing various reasons, such as competition, partnership, or another connections with any of the researchers and institutions involved in the conflict of interest articles, should not be assessed by the reviewers.
Copyright Policy
Open Access (OA)
All articles published in IJDO are open access which means the articles are freely available online for anyone to download and use the providing address to the individual authors. In IJDO as an open access journal, authors sign a publishing agreement where they will have copyright but grant broad publishing and distribution rights to the publisher, including the right to publish the article on IJDO's website and choose the end-user license under which readers can use and share the articles. Then IJDO provides the article's online access for using and sharing by readers. Permitted (re) use is defined by Creative Commons Attribution (CC BY 4.0).
Creative Commons Attribution (CC BY 4.0): permit users to copy, to create extracts abstracts, abstracts and new works from the article, to alter and revise the article, and to make commercial use of the article
Copyright Form
Conflicts of interest
All authors must inform us about any kind of financial, personal, political, or academic "Conflict of Interest that would potentially affect their judgment. Authors are preferably asked to fill the uniform disclosure form available through: (http://www.icmje.org/coi_disclosure.pdf). We then use the COPE guidelines to clearly deal with it.
Page fee
There is no fee for submission, review, or publishing an article in this journal in both online and print forms.
Advertising policy
The journal does not carry advertising (neither print nor online).
Complaints and appeals
We hope this never happens, but if you do, the best way to contact us is by email (ijdo2009
gmail.com). The complaint should clearly include the subject, person, or event related to the IJDO. The relevant member of the editorial board will review the complaint as soon as possible, and if the problem is not resolved, the complaints will be referred to the IJDO editorial board and complete response will be provided within a week. If the problem is not resolved, the complaint will be sent to the Research Ethics Committee of Shahid Sadoughi University and will be answered within four weeks. If the plaintiff remains dissatisfied, a complaint must be sent to the chief administrator of Shahid Sadoughi University of Medical Sciences, which ends with his decision.Notice
- Ethics committee approval code is necessary for all type of manuscripts.
- Although this journal is not yet a member of COPE, but Ethics and malpractice statements of the Iranian Journal of Diabetes and Obesity are according to COPE’s Best Practice Guidelines for Journal Editors and related to all individuals associated with the publishing: the editor, the peer reviewer and the author.
View: 2714 Time(s) |
Print: 395 Time(s) |
Email: 0 Time(s) |
0 Comment(s)
